Literature DB >> 9343401

Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability.

L Marusíc1, M Anton, A Tidy, P Wang, B Villeponteau, S Bacchetti.   

Abstract

Telomerase synthesizes telomeric DNA by copying the template sequence of its own RNA component. In Tetrahymena thermophila and yeast (G. Yu, J. D. Bradley, L. D. Attardi, and E. H. Blackburn, Nature 344:126-131, 1990; M. McEachern and E. H. Blackburn, Nature 376:403-409, 1995), mutations in the template domain of this RNA result in synthesis of mutant telomeres and in impaired cell growth and survival. We have investigated whether mutant telomerase affects the proliferative potential and viability of immortal human cells. Plasmids encoding mutant or wild-type template RNAs (hTRs) of human telomerase and the neomycin resistance gene were transfected into human cells to generate stable transformants. Expression of mutant hTR resulted in the appearance of mutant telomerase activity and in the synthesis of mutant telomeres. Transformed cells were not visibly affected in their growth and viability when grown as mass populations. However, a reduction in plating efficiency and growth rate and an increase in the number of senescent cells were detected in populations with mutant telomeres by colony-forming assays. These results suggest that the presence of mutant telomerase, even if coexpressed with the wild-type enzyme, can be deleterious to cells, likely as a result of the impaired function of hybrid telomeres.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343401      PMCID: PMC232491          DOI: 10.1128/MCB.17.11.6394

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

Authors:  R K Moyzis; J M Buckingham; L S Cram; M Dani; L L Deaven; M D Jones; J Meyne; R L Ratliff; J R Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Characterization of a newly derived human sarcoma cell line (HT-1080).

Authors:  S Rasheed; W A Nelson-Rees; E M Toth; P Arnstein; M B Gardner
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.

Authors:  A M Olovnikov
Journal:  J Theor Biol       Date:  1973-09-14       Impact factor: 2.691

7.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

8.  SnRNAs, SnRNPs, and RNA processing.

Authors:  H Busch; R Reddy; L Rothblum; Y C Choi
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

9.  Telomeric repeat from T. thermophila cross hybridizes with human telomeres.

Authors:  R C Allshire; J R Gosden; S H Cross; G Cranston; D Rout; N Sugawara; J W Szostak; P A Fantes; N D Hastie
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

10.  Human U2 small nuclear RNA genes contain an upstream enhancer.

Authors:  M Mangin; M Ares; A M Weiner
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  31 in total

1.  Three telomerases with completely non-telomeric template replacements are catalytically active.

Authors:  T L Ware; H Wang; E H Blackburn
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Dynamics of telomeric DNA turnover in yeast.

Authors:  Michael J McEachern; Dana Hager Underwood; Elizabeth H Blackburn
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

3.  Molecular targeting of cancer: telomeres as targets.

Authors:  R Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  A human telomerase-associated nuclease.

Authors:  Rena Oulton; Lea Harrington
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

5.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.

Authors:  M M Kim; M A Rivera; I L Botchkina; R Shalaby; A D Thor; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

6.  Specific telomerase RNA residues distant from the template are essential for telomerase function.

Authors:  J Roy; T B Fulton; E H Blackburn
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

7.  The terminal telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion.

Authors:  Bradley A Stohr; Lifeng Xu; Elizabeth H Blackburn
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

8.  "Poisoning" yeast telomeres distinguishes between redundant telomere capping pathways.

Authors:  Noa Lamm; Shhadeh Bsoul; Majdi M Kabaha; Yehuda Tzfati
Journal:  Chromosoma       Date:  2012-10-06       Impact factor: 4.316

9.  Yeast telomerase is specialized for C/A-rich RNA templates.

Authors:  Klaus Förstemann; Arthur J Zaug; Thomas R Cech; Joachim Lingner
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

Review 10.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.